FDA Warns Dexcom Over Glucose Monitor Problems

Law360, New York (June 2, 2010, 1:41 PM EDT) -- Medical device maker Dexcom Inc. failed to file reports that its blood glucose monitors had sensor malfunctions that could cause serious injury or death, the U.S. Food and Drug Administration contends.

Sensors broke off from Dexcom's Seven Plus series of blood monitors and remained embedded in the skin of dozens of patients, the FDA said in a warning letter to Dexcom publicized Tuesday.

The company was required to report the malfunctions to the FDA, but did not, the FDA said.

Under the Medical Device Reporting regulation...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.